Keyword Suggestion
Domain Informations
Breyanzi.com lookup results from whois.corporatedomains.com server:
- Domain created: 2018-08-14T21:41:32Z
- Domain updated: 2026-08-10T05:04:14Z
- Domain expires: 2027-08-14T21:41:32Z 0 Years, 357 Days left
- Website age: 8 Years, 7 Days
- Registrar Domain ID: 2297640308_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- NS1.BMS.COM
- NS2.BMS.COM
- NS3.BMS.COM
- NS4.BMS.COM
Network
- inetnum : 45.60.0.0 - 45.60.255.255
- name : THALES-IMPERVA-NA4-AGG-45-60
- handle : NET-45-60-0-0-1
- status : Direct Allocation
- created : 2010-09-15
- changed : 2026-03-16
Owner
- organization : Incapsula Inc
- handle : INCAP-5
- address : Array,SAN MATEO,CA,94403,US
Abuse
- handle : ABUSE9265-ARIN
- name : Abuse
- phone : +1-650-345-9000
- email : [email protected]
Technical support
- handle : NETEN40-ARIN
- name : NetEng
- phone : +1-650-345-9000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 45.60.162.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 45.60.162.161)
Spam Check (IP: 45.60.162.161)
Recent Searched Sites
› Cermag24.pl (1 seconds ago) / PL
› Help.sparkedhost.com (5 seconds ago) / US
› Hmonghomehealthcare.com (1 seconds ago) / US
› Breyanzi.com (1 seconds ago) / US
› Gpdnr.su (2 seconds ago) / UA
› Leanyfaluiskola.hu (0 seconds ago) / HU
› Marketing.orderlymeds.com (6 seconds ago) / US
› Nikhilsharma.com (0 seconds ago) / US
› Eduwullsion.com (2 seconds ago) / CN
› Ids.nic.in (2 seconds ago) / IN
› Junkissa.jp (0 seconds ago) / US
› Player.pop.co.uk (4 seconds ago) / GB
› Afaf11.com (3 seconds ago) / HK
› Otc.janeapp.com (5 seconds ago) / US
› Showroom.eskk.pl (1 seconds ago) / PL
› Aurora-vitra.com (0 seconds ago) / DE
› Wedega.com (3 seconds ago) / CH
› Notebookheavy.com (20 seconds ago) / US
› Pruzhany-rkbo.by (0 seconds ago) / BY
› Wffpro.tidyhq.com (3 seconds ago) / US
Websites Listing
We found Websites Listing below when search with breyanzi.com on Search Engine
Large B-Cell Lymphoma Treatment | Breyanzi® …
BREYANZI can lower one or more types of your blood cells (red blood cells, white blood cells, or platelets). After treatment, your healthcare provider will test your blood to check for this. Tell your healthcare provider right away if you get …
Breyanzi.comCAR T Therapy Treatment Center | Breyanzi® …
Before you get BREYANZI, you will get 3 days of chemotherapy to prepare your body. When your BREYANZI is ready, your healthcare provider will give it to you through a catheter placed into your vein. BREYANZI is given as infusions of 2 different cell types. You will receive infusions of one cell type, immediately followed by the other cell type.
Breyanzi.comBREYANZI REMS Training
Online at BreyanziREMS.com, via email [email protected], or by fax to 1-855-496-8607. •Submit a successfully completed BREYANZI REMS Hospital Enrollment Form to Juno online at BreyanziREMS.com, via email [email protected], or by fax to 1-855-496-8607. •Oversee the implementation of and compliance with BREYANZI REMS in hospitals …
Media.breyanzirems.comCHMP recommends approval for Bristol's Breyanzi to treat ...
Bristol Myers Squibb cellular therapy development senior vice president Anne Kerber said: “This positive CHMP opinion is an important milestone that recognizes Breyanzi as a differentiated cell therapy with the potential to address unmet needs for patients in the European Union with aggressive lymphomas who have limited treatment options.
Pharmaceutical-business-review.comNew CAR T-Cell Therapy Breyanzi Approved for R/R B-Cell ...
2021-02-12 · In the single-arm, open-label, multicenter trial (ClinicalTrials.gov Identifier: NCT02631044), 268 patients with R/R large B-cell lymphoma, including those with high-risk disease, received lisocabtagene maraleucel preceded by lymphodepleting chemotherapy. Of these, 192 patients received 50 to 110×10 6 CAR-positive viable T cells and were ...
Clinicaloncology.comBREYANZI - Juno Therapeutics, Inc. Trademark Registration
2019-08-07 · The mark consists of "BREYANZI" in dark blue font with an orange dot over the "I" with a sunburst design behind and above the "ZI" with half of the dots in the upper side in dark blue dots and the other half of the dots in the lower side in light blue dots. Status 2021-02-05 UTC Refresh . LIVE APPLICATION Under Examination The trademark application has been …
Uspto.reportBMS Touts Breyanzi's Outpatient Administration As EU ...
2022-02-01 · Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: BMS Touts Breyanzi's Outpatient Administration As EU Approval Beckons Add a personalized message to your email
Scrip.pharmaintelligence.informa.comBristol Myers Squibb - Bristol Myers Squibb Receives ...
2022-01-28 · “This positive CHMP opinion is an important milestone that recognizes Breyanzi as a differentiated cell therapy with the. See All Press Releases . Sign up for Email Alerts. Press Release RSS. Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B. …
News.bms.comBristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel ...
2021-12-11 · Breyanzi is not indicated for the treatment of patients with primary central nervous system lymphoma. Breyanzi is also approved in Japan for third-line plus relapsed and refractory LBCL, and Marketing Authorization Applications for Breyanzi for this indication are currently under review in the European Union, Switzerland and Canada. Bristol Myers Squibb’s clinical …
Ca.movies.yahoo.comFDA approves Breyanzi, new treatment for B-cell lymphoma
2021-08-02 · FDA approves Breyanzi, new treatment for B-cell lymphoma. 08-02-2021. Comments (0) Print. More on this story. Article Celgene shareholders sue BMS over alleged Breyanzi stalling. 04-06-2021. Article Japan’s MHLW approves a new CAR-T cell therapy, Breyanzi. 26-03-2021.
Thepharmaletter.comCurrent status and perspective of CAR-T and CAR-NK cell ...
2021-03-22 · Fig. 1: Schematic illustration of a CAR-T or CAR-NK cell therapy, which uses primary immune cells. (1) T or NK cells are isolated from the patient’s or donor’s blood. (2) Subsequently, cells ...
Nature.comBristol Myers Squibb Receives Positive CHMP Opinion for ...
2022-01-28 · PRINCETON, N.J., January 28, 2022--BMS Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B
Finance.yahoo.comBreyanzi Coupon & Prices - Cost $49 per month
Breyanzi is available as a cell suspension for infusion, in the following doses: A single dose of Breyanzi contains 50 to 110 × 106 CAR positive viable T cells (consisting of 1:1 CAR-positive viable T cells of the CD8 and CD4 components), with each component, supplied separately in one to four single-dose 5 mL vials. Each mL contains 1.5 × 106 to 70 × 106 CAR-positive viable T …
Nicerx.comBristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel ...
2021-12-11 · PRINCETON, N.J., December 11, 2021--Bristol Myers Squibb’s Breyanzi Significantly Improves Outcomes, Showing Superiority Over 20-Year Standard of Care....
Ca.news.yahoo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| gemibook.com | namesilo.com | -3 Years, -277 Days |
| gnttv.com | godaddy.com | -3 Years, -55 Days |
| celesthealth.com | tucows.com | -3 Years, -278 Days |
| enhancedarsenal.com | enomdomains.com | -3 Years, -236 Days |
| otviptv.com | wanwang.aliyun.com | -3 Years, -165 Days |
| gamebai.club | namecheap.com | -3 Years, -195 Days |
| topsmetering.com | 72e.net | -3 Years, -293 Days |
| medytour.com | openprovider.com | -3 Years, -233 Days |
| freebnbco.in | namecheap.com | -3 Years, -172 Days |
| antiquegallerylewisville.com | godaddy.com | -2 Years, -107 Days |